𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of transgenic endothelial progenitor cell-seeded stents

✍ Scribed by Zhenhua Zhou; Shugui Shi; Mingbao Song; Heqing Huang; Kangning Chen; Jianhong Mi; Lusi Li; Guisheng Chen; Chunli Hou; Guangyu Huang; Chuhong Zhu


Book ID
102295782
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
281 KB
Volume
91A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Endothelial progenitor cell (EPC)‐seeded intravascular stents may reduce or prevent in‐stent restenosis. A20 can play an important role for preventing vascular restenosis. Therefore, it is very important how to enhance the seeding efficiency of A20‐modified EPCs on the stent for preventing in‐stent restenosis. To approach this problem, we developed a novel transgenic EPC‐seeded stent and evaluated its feasibility and efficiency. EPCs were isolated and purified from umbilical blood using immunomagnetic beads and then transfected with the A20 gene. One stent type (type 1) was coated with EDC cross‐linked collagen, and another stent type (type 2) was coated with EDC cross‐linked collagen and bound to the CD34 antibody using the bifunctional coupling agent N‐succinmidyl3‐(2‐pyridyldithio) propionate (SPDP). Then, the stents were seeded with EPCs transfected with the A20 gene. The stents were implanted in biological artificial vessels, and cell adhesion was determined in a flow chamber. Cell growth was also measured. EPCs were transfected successfully with the A20 gene. The cells covered both types of stents with favorable biological function. After placement in a flow chamber, the number of cells attached to type 1 stents significantly dropped and their distribution was scattered. Type 2 stents were basically covered with cells and there were more cells on type 2 stents than on type 1 stents (p < 0.01). Collagen‐coupled antibody effectively improves the seeding of transgenic EPCs, offering a new choice of stents to prevent restenosis caused by vascular disease after interventional treatment.© 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009


📜 SIMILAR VOLUMES


Development of a novel endothelial cell-
✍ Wei Zhu; Yanlong Tian; Liang-Fu Zhou; Yang Wang; Donglei Song; Ying Mao; Guo-Yua 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

## Abstract The metallic stent has been widely used in endovascular treatment of intracranial aneurysms and arterial stenosis. Endothelialization at the neck of the aneurysm or stenotic lesion after stent deployment plays a pivotal role in preventing aneurysm recurrence, as well as local thrombus f

Promotion of osteogenesis in tissue-engi
✍ Haiying Yu; Pamela J. VandeVord; Weiming Gong; Bin Wu; Zheng Song; Howard W. Mat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 252 KB

## Abstract In addition to a biocompatible scaffold and an osteogenic cell population, tissue‐engineered bone requires an appropriate vascular bed to overcome the obstacle of nutrient and oxygen transport in the 3D structure. We hypothesized that the addition of endothelial cells (ECs) may improve